Cargando…
Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.
Autor principal: | Younes, Cherradi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256602/ https://www.ncbi.nlm.nih.gov/pubmed/32527653 http://dx.doi.org/10.1016/j.dld.2020.05.039 |
Ejemplares similares
-
Hypertensive Crisis in Pregnancy with COVID19: Confirmed with rt-PCR for Nasopharyngeal Swab
por: Bandara, Sajith, et al.
Publicado: (2020) -
Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy Results
por: Kyle, Barry D, et al.
Publicado: (2020) -
Can 2 Different Fecal Calprotectin Assays be Used Interchangeably in IBD Treatment?
por: van Wassenaer, Elsa A., et al.
Publicado: (2022) -
Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR
por: Tsujimoto, Yoshie, et al.
Publicado: (2021) -
SARS-COV-2 detection in saliva and nasopharyngeal swabs using RT-PCR
was similar
por: Guimarães, Taísa Coelho, et al.
Publicado: (2022)